Pages that link to "Q33976203"

The following pages link to Valproic acid induces Notch1 signaling in small cell lung cancer cells (Q33976203):

Displaying 19 items.

• Targeting the epigenome in lung cancer: expanding approaches to epigenetic therapy (Q24609974) (← links)
• Inhibition of growth in medullary thyroid cancer cells with histone deacetylase inhibitors and lithium chloride (Q33804934) (← links)
• Long-term use of valproic acid in US veterans is associated with a reduced risk of smoking-related cases of head and neck cancer. (Q33915416) (← links)
• The Histone Deacetylase Inhibitor Vaproic Acid Induces Cell Growth Arrest in Hepatocellular Carcinoma Cells via Suppressing Notch Signaling (Q36048511) (← links)
• Potential Therapeutic Role of Z-Isochaihulactone in Lung Cancer through Induction of Apoptosis via Notch Signaling. (Q36291949) (← links)
• The HDAC inhibitor panobinostat (LBH589) inhibits mesothelioma and lung cancer cells in vitro and in vivo with particular efficacy for small cell lung cancer (Q36709317) (← links)
• Combination therapy with histone deacetylase inhibitors and lithium chloride: a novel treatment for carcinoid tumors (Q37339815) (← links)
• Epigenetic therapy of lymphoma using histone deacetylase inhibitors (Q37763784) (← links)
• Correlation between histone acetylation and expression of Notch1 in human lung carcinoma and its possible role in combined small-cell lung carcinoma. (Q38707443) (← links)
• Notch1 signaling is irresponsible to the anti-leukemic effect of HDACis in B-ALL Nalm-6 cells (Q39280883) (← links)
• Hesperetin, a potential therapy for carcinoid cancer (Q39583082) (← links)
• Does valproic acid induce neuroendocrine differentiation in prostate cancer? (Q39638991) (← links)
• Valproic acid suppresses cervical cancer tumor progression possibly via activating Notch1 signaling and enhances receptor-targeted cancer chemotherapeutic via activating somatostatin receptor type II. (Q45912062) (← links)
• Targeted therapy of gastroenteropancreatic neuroendocrine tumours: preclinical strategies and future targets (Q47393972) (← links)
• Phase I trial of belinostat with cisplatin and etoposide in advanced solid tumors, with a focus on neuroendocrine and small cell cancers of the lung. (Q50115429) (← links)
• Evaluation of role of Notch3 signaling pathway in human lung cancer cells. (Q52886289) (← links)
• Large-cell neuroendocrine carcinoma of the ampulla of Vater (Q84867723) (← links)
• Analysis of the Differentially Expressed Genes Induced by Cisplatin Resistance in Oral Squamous Cell Carcinomas and Their Interaction (Q89621433) (← links)
• Primary infection by Pneumocystis induces Notch-independent Clara cell mucin production in rat distal airways (Q92562506) (← links)